StonvexLoading…
StonvexStonvexStonvexCore line items from SCCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.42B | $11.43B | $9.90B | $10.05B |
Operating Income | $7.00B | $5.55B | $4.19B | $4.44B |
Net Income | $4.35B | $3.39B | $2.43B | $2.65B |
EPS (Diluted) | $5.24 | $4.21 | $3.05 | $3.41 |
Total Assets | $21.38B | $18.71B | $16.73B | $17.28B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $4.30B | $3.26B | $1.15B | $2.07B |
Free Cash Flow OCF − CapEx | $3.43B | $3.39B | $2.56B | $1.85B |
Shares Outstanding | 826.60M | 802.90M | 795.30M | 773.10M |